We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-7 of 7

FTC requires divestiture of pharmaceutical and medical data analytics components to clear IMS health’s acquisition of SDI health

  • Hogan Lovells
  • -
  • USA
  • -
  • June 12 2012

In October 2011, the FTC required Healthcare Technology Holdings, Inc. to divest SDI Health’s promotional audit and medical audit business lines in order for Health Technology’s subsidiary, IMS Health to consummate its acquisition of SDI

Court to tackle "state action" for the first time in 20 years

  • Hogan Lovells
  • -
  • USA
  • -
  • October 23 2012

On 26 November, the U.S. Supreme Court will hear argument in FTC v. Phoebe Putney Health System, No. 11-1160, its first case in 20 years about "state action" immunity under the antitrust laws

FDA's financial disclosure regulations: careful compliance in a changing landscape Part 1

  • Hogan Lovells
  • -
  • USA
  • -
  • January 14 2011

At first glance, compliance with US Food and Drug Administration (FDA) financial disclosure regulations set forth in 21 CFR Part 54 looks straightforward

Supreme Court tightens the scope of antitrust immunity in Government-owned hospital mergers

  • Hogan Lovells
  • -
  • USA
  • -
  • February 22 2013

In a unanimous and favorable decision for the Federal Trade Commission (FTC), the Supreme Court found that the state action immunity doctrine does

SFDA clarifies rules for address changes following cross-province mergers of medical device manufacturers

  • Hogan Lovells
  • -
  • China
  • -
  • June 30 2009

On June 2, 2009, the State Food and Drug Administration of the PRC (SFDA) issued a letter to clarify the procedural rules relating to change of address applications filed by medical device manufacturers that conduct cross-province mergers and acquisitions

Antitrust, competition and economic regulation client quarterly newsletter

  • Hogan Lovells
  • -
  • China, European Union, Greece, USA
  • -
  • January 24 2012

A public company CEO recently consented to a federal district court order requiring him to pay a $500,000 civil penalty for violating the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR Act”

China liberalizes foreign investment in medical services sector

  • Hogan Lovells
  • -
  • China
  • -
  • December 15 2010

On 26 November 2010, the State Council circulated the Opinions on Further Encouraging and Guiding the Use of Non-governmental Capital in the Establishment of Medical Institutions ("Opinions"

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy